Citalopram, Fluoxetine, and Paroxetine (Combination)

The query concerns a hypothetical combination of three distinct selective serotonin reuptake inhibitors (SSRIs): citalopram, fluoxetine, and paroxetine. These are separate medications and are not typically prescribed together as a single combination drug due to similar mechanisms of action and a significant increase in the risk of serotonin syndrome, a potentially serious condition. Each SSRI has its own characteristics, side effects, and approved uses. They also affect the cytochrome P450 enzyme system differently; for instance, fluoxetine and paroxetine are inhibitors of CYP2D6, and fluoxetine also inhibits CYP2C19.